DYN
Price
$9.96
Change
+$0.74 (+8.02%)
Updated
Apr 2, 03:06 PM (EDT)
Capitalization
1.04B
29 days until earnings call
ROIV
Price
$10.08
Change
+$0.23 (+2.34%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
7.03B
84 days until earnings call
Ad is loading...

DYN vs ROIV

Header iconDYN vs ROIV Comparison
Open Charts DYN vs ROIVBanner chart's image
Dyne Therapeutics
Price$9.96
Change+$0.74 (+8.02%)
Volume$350
Capitalization1.04B
Roivant Sciences
Price$10.08
Change+$0.23 (+2.34%)
Volume$105.17K
Capitalization7.03B
DYN vs ROIV Comparison Chart
Loading...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DYN vs. ROIV commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a StrongBuy and ROIV is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (DYN: $9.23 vs. ROIV: $9.85)
Brand notoriety: DYN and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 400% vs. ROIV: 161%
Market capitalization -- DYN: $1.04B vs. ROIV: $7.03B
DYN [@Biotechnology] is valued at $1.04B. ROIV’s [@Biotechnology] market capitalization is $7.03B. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 1 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • DYN’s FA Score: 1 green, 4 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, ROIV is a better buy in the long-term than DYN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 4 TA indicator(s) are bullish while ROIV’s TA Score has 4 bullish TA indicator(s).

  • DYN’s TA Score: 4 bullish, 4 bearish.
  • ROIV’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, DYN is a better buy in the short-term than ROIV.

Price Growth

DYN (@Biotechnology) experienced а -25.50% price change this week, while ROIV (@Biotechnology) price change was -7.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.95%. For the same industry, the average monthly price growth was -7.12%, and the average quarterly price growth was -11.69%.

Reported Earning Dates

DYN is expected to report earnings on May 01, 2025.

ROIV is expected to report earnings on Jun 25, 2025.

Industries' Descriptions

@Biotechnology (-4.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($7.03B) has a higher market cap than DYN($1.04B). ROIV YTD gains are higher at: -16.737 vs. DYN (-60.823). ROIV has higher annual earnings (EBITDA): 4.1B vs. DYN (-342.21M). ROIV has more cash in the bank: 5.15B vs. DYN (642M). DYN has less debt than ROIV: DYN (24M) vs ROIV (100M). ROIV has higher revenues than DYN: ROIV (123M) vs DYN (0).
DYNROIVDYN / ROIV
Capitalization1.04B7.03B15%
EBITDA-342.21M4.1B-8%
Gain YTD-60.823-16.737363%
P/E RatioN/A1.97-
Revenue0123M-
Total Cash642M5.15B12%
Total Debt24M100M24%
TECHNICAL ANALYSIS
Technical Analysis
DYNROIV
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
57%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
69%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 16 days ago
86%
Bullish Trend 14 days ago
71%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTUAX58.18N/A
N/A
Fidelity Advisor Telecommunications A
ODVYX39.02N/A
N/A
Invesco Developing Markets Y
ABCSX15.56N/A
N/A
AB Discovery Value C
IARYX17.08N/A
N/A
Invesco Real Estate Y
GFSIX16.39N/A
N/A
Gabelli Global Financial Services I

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with CRNX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
-11.76%
CRNX - DYN
48%
Loosely correlated
-8.71%
INZY - DYN
47%
Loosely correlated
-4.40%
MRSN - DYN
46%
Loosely correlated
-2.88%
IGMS - DYN
45%
Loosely correlated
N/A
RNA - DYN
43%
Loosely correlated
-9.42%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
-2.38%
IMVT - ROIV
53%
Loosely correlated
-11.06%
DYN - ROIV
44%
Loosely correlated
-11.76%
ACLX - ROIV
43%
Loosely correlated
-7.47%
AXON - ROIV
43%
Loosely correlated
+2.90%
KRYS - ROIV
42%
Loosely correlated
-3.17%
More